

NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for
You can purchase shares of Nanoviricides (AMEX:NNVC) through any online brokerage.
Other companies in Nanoviricides’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Nanoviricides has a consensus price target of $6.25.
The stock price for Nanoviricides (AMEX: NNVC) is $1.31 last updated November 6, 2026 at 7:10 PM EST.
There are no upcoming dividends for Nanoviricides.
Nanoviricides does not have any upcoming earnings scheduled.
There is no upcoming split for Nanoviricides.
Nanoviricides is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the...